SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026)

SS Innovations International (SSII) reported Liabilities and Shareholders Equity of $90.5 million for Q1 2026, up 42.69% on a YoY basis from $63.5 million in Q1 2025, and up 21.99% sequentially from $74.2 million in Q4 2025.

SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

SS Innovations International (SSII) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $90.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 42.69% year-over-year to $90.5 million; the trailing twelve-month figure through Mar 2026 stood at $304.3 million (up 68.57% YoY), and the FY2025 full-year result was $74.2 million, up 75.12% from the prior year.
  • Liabilities and Shareholders Equity climbed to $90.5 million in Q1 2026, from $74.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.5 million in Q1 2026 to a low of $279336.0 in Q2 2022.
  • A 5-year average of $35.7 million and a median of $35.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity sank 36.52% in 2022 and jumped 4349.77% in 2023, its largest moves.
  • Tracing SSII's Liabilities and Shareholders Equity over 5 years: stood at $7.0 million in 2022, then jumped by 351.48% to $31.5 million in 2023, then soared by 34.49% to $42.4 million in 2024, then surged by 75.12% to $74.2 million in 2025, then climbed by 21.99% to $90.5 million in 2026.
  • Business Quant data shows SSII's Liabilities and Shareholders Equity at $90.5 million in Q1 2026, $74.2 million in Q4 2025, and $69.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 SS Innovations International 699.75 Mn 676.14 Mn 5.33 Mn 90.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.55 Mn
Dec 31, 2025 74.23 Mn
Sep 30, 2025 69.58 Mn
Jun 30, 2025 69.98 Mn
Mar 31, 2025 63.46 Mn
Dec 31, 2024 42.39 Mn
Sep 30, 2024 39.02 Mn
Jun 30, 2024 35.67 Mn
Mar 31, 2024 35.20 Mn
Dec 31, 2023 31.52 Mn
Sep 30, 2023 28.16 Mn
Jun 30, 2023 12.43 Mn
Mar 31, 2023 5.47 Mn
Dec 31, 2022 6.98 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 279,336.00
Mar 31, 2022 367,396.00
Dec 31, 2021 428,607.00
Sep 30, 2021 334,401.00
Jun 30, 2021 440,038.00